ClinicalTrials.gg
RecruitingNCT06888895EFIM2Updated Nov 25, 2025

Comparison of the Immediate Effect of Passive vs. Passive-Active Hamstring Stretching on Flexibility in Patients With Chronic Low Back Pain

An interventional study of Passive-active stretching (PAS) and Passive hamstring stretching in Chronic Low Back Pain (CLBP), sponsored by University Hospital, Clermont-Ferrand. Recruiting at 2 sites in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-11-25.

Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Low Back Pain with a site in France — 30 open to participants now, 33 under way, 5 of them phase 3. Low Back Pain · France.

Planned enrollment
37th of 79
90 · median 82
Started
2025
with 9 others
No phase
61 of 114
21 open now
Primary completion
2028-04
later than 28 of 32 live
Registered
99th of 114
by date
Lead sponsor
6 of 114
University Hospital, Clermont-Ferrand

Among the 114 studies in Low Back Pain with a site in France, this one is the 37th largest by planned enrollment of the 79 interventional ones that give a count, is one of 10 that started in 2025, is one of 61 with no phase, reaches primary completion later than 28 of the 32 other live ones, and was the 99th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

30 of the 114 studies in Low Back Pain with a site in France are open now. Recruiting first, the newest first:

24 more — sign in →

All 30 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Low Back Pain with a site in France, or all of them as a file.
02

Study summary

The goal of this clinical trial is to determine whether a combination of passive and active hamstring stretching (PAS) is more effective than passive stretching alone (PS) in improving flexibility in patients with chronic low back pain (CLBP).

The main questions it aims to answer are:

Does PAS lead to greater improvements in active flexibility compared to PS? Does PAS provide additional benefits in passive flexibility, hamstring stiffness, and pelvic tilt? Researchers will compare the PAS group and the PS group to see if combining passive and active stretching results in greater improvements in flexibility and movement control.

Participants will:

Perform either PAS or PS stretching exercises as assigned. Undergo measurements of flexibility, hamstring stiffness, and pelvic tilt before and after the intervention.

Answer a question about their perceived change in flexibility following the intervention.

This study aims to improve rehabilitation strategies for people with CLBP, helping them achieve better movement and pain relief.

Read the detailed description

Individuals with chronic low back pain (CLBP) are affected by deficits in hamstring flexibility and lumbopelvic neuromuscular control. While passive hamstring stretching immediately improves passive hamstring flexibility, no clinically important difference in active range of motion has been observed.

The primary objective of the present randomized controlled study protocol is to compare the immediate effects of a novel combination of passive and active stretching (PAS) exercises with passive hamstring stretching (PS) alone on active flexibility.

The secondary objectives include conducting a similar comparison for passive flexibility, hamstring stiffness, and pelvic tilt, as well as estimating the Minimal Clinically Important Difference (MCID) for hamstring flexibility measures. Ninety CLBP patients will be randomized into PAS or PS group and will receive respective interventions. Primary outcome will be the mean value of two measurements of Active Knee Extension taken before and immediately after the intervention. Secondary outcomes, Fingertip-to-Floor distance, Straight Leg Raise, hamstring stiffness and pelvic tilt will be recorded and compared in the same manner. A group-by-time comparison will be conducted for primary and secondary outcomes. An anchor question about perceived by participants change in flexibility following intervention will serve to estimate MCID.

This study protocol is the first opportunity to assess whether combining passive and active hamstring stretching is better than passive stretching alone for achieving an immediate and clinically important improvement in active flexibility among CLBP patients. The results will provide valuable and time-efficient insights for the development of more comprehensive rehabilitation programs in both clinical and research settings.

03

Conditions studied

  • Chronic Low Back Pain (CLBP)

Browse trials for

Keywords

  • hamstring
  • chronic low back pain
  • extensibility deficit
  • passive stretching
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male or female patients aged between 18 and 65 years
  • Suffering from low-back pain for at least 3 months
  • Presenting with hamstring flexibility deficit (Straight Leg Raise \<85°, Fingertip-to-Floor distance >5 cm)

Exclusion criteria

Exclusion Criteria:

  • Patients with radicular pain
  • Disc inflammation (MODIC Type 1)
  • Other relevant pathologies (neurological, cardiovascular, respiratory, or oncological diseases)
  • Significant surgical history (e.g., lumbar arthrodesis, knee or hip arthroplasty)
  • Pregnancy or breastfeeding
  • Patients under protective legal measures
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    Passive stretching (PS)

    In the control group, participants will receive one minute of passive hamstring stretching applied three times for each lower limb, with a 30-second rest time between stretches. This ensures that the intervention time is consistent across both groups, totaling approximately 15-20 minutes.

    Other: Passive hamstring stretching

  • Experimental
    Passive-Active Stretching (PAS)

    The passive-active stretching (PAS) intervention has two phases. In the first, a physiotherapist performs bilateral passive hamstring stretching, followed by a 30-second walk. The second phase includes three exercises with 30-second rest intervals between them. Active Knee Extension: The participant lies on their back with one thigh vertical (hip at 90°). A Stabilizer® Pressure Bio-feedback device is placed behind the lumbar spine to help maintain neutral position. The participant maintains 40 mmHg pressure while extending the knee to its maximum. Ten repetitions with a 3-second hold are performed. One-Leg Deadlift: While balancing on one leg, the participant bends forward and lifts the opposite leg, targeting hamstring elongation. Ten repetitions with a 5-second hold are performed. Bear-Squat Exercise: Starting in all-fours, participants shift weight onto toes and hands, moving the pelvis backward to elongate the hamstrings. Ten repetitions are performed.

    Other: Passive-active stretching (PAS)

Interventions

  • OtherPassive-active stretching (PAS)

    Passive-active stretching (PAS) combines conventional passive stretching with active exercises designed to activate muscles that promote hamstring elongation. On the other hand, passive stretching (PS) is a commonly administered intervention to improve hamstring flexibility.

    Also known as: Passive stretching (PS)

  • OtherPassive hamstring stretching

    Participants will receive one minute of passive hamstring stretching applied three times for each lower limb, with a 30-second rest time between stretches.

06

What researchers measure

Primary outcomes

  1. Active Knee Extension (AKE)

    The Active Knee Extension (AKE) angle will be evaluated at baseline and immediately after the intervention. The mean value of the two measurements taken before the intervention will be compared with the mean value of two measurements taken immediately after the intervention. The change in AKE values of the less flexible lower limb, expressed as a percentage relative to the initial value, will be used to compare the effect between the PS and PAS groups. The participants will extend the tested knee as much as possible while keeping their thigh vertical against a plastic stick placed along the anterior surface of their thigh (maintaining 90° hip flexion). The rater will position the EasyAngle® digital inclinometer on the tibial crest, just below the tibial tuberosity, to record the maximal knee extension angle.

    Time frame: Before and immediately after the intervention

Secondary outcomes

  1. Fingertip-to-Floor distance (FTF)

    The FTF distance will be evaluated at baseline and immediately after the intervention. The mean value of the two measurements taken before the intervention will be compared with the mean value of two measurements taken immediately after the intervention. The change in FTF values, expressed as a percentage relative to the initial value, will be used to compare the effect between the PS and PAS groups. The FTF measurement will be conducted in the standard manner by measuring the distance between the fingertips and the floor using a measuring tape at the end of the forward bending range, with knees fully extended.

    Time frame: Before and immediately after the intervention

  2. Pelvic tilt angle

    The pelvic tilt angle will be measured at baseline and immediately after the intervention. The mean value of the two measurements taken before the intervention will be compared with the mean value of two measurements taken immediately after the intervention. The change in pelvic tilt angle values, expressed as a percentage relative to the initial value, will be used to compare the effect between the PS and PAS groups. The EasyAngle® inclinometer will be placed on the sacrum to measure the sagittal plane angle between the pelvis position in the erect standing posture and its position at the end of forward trunk bending, as in the FTF measurement.

    Time frame: Before and immediately after intervention

  3. Straight Leg Raise (SLR) angle

    The SLR angle will be evaluated at baseline and immediately after the intervention. The mean value of the two measurements taken before the intervention will be compared with the mean value of two measurements taken immediately after the intervention. The change in SLR angle values of the less flexible lower limb, expressed as a percentage relative to the initial value, will be used to compare the effect between the PS and PAS groups. The rater will raise the participant's lower limb with the knee fully extended until the first sensation of stretch or pain is felt. The angle will then be recorded using the EasyAngle® digital inclinometer, which will be secured with a Velcro strap to the lateral side of the lower limb at the level of the tibial tuberosity.

    Time frame: Before and immediately after the intervention

  4. Hamstring stiffness

    Hamstring stiffness during the SLR maneuver will be measured at baseline and immediately after the intervention. The mean value of the two measurements taken before the intervention will be compared with the mean value of two measurements taken immediately after the intervention. The change in hamstring stiffness of the less flexible lower limb, expressed as a percentage relative to the initial value, will be used to compare the effect between the PS and PAS groups. The pulling force applied during the SLR maneuver will be recorded in Newtons using the EasyForce® digital dynamometer.

    Time frame: Before and immediately after the intervention

  5. Pain Visual Analogue Scale (VAS)

    Pain will be assessed using the Visual Analogue Scale (VAS), where 0 represents no pain and 100 represents the maximum imaginable pain, at the end of the SLR angle before the intervention. The post-intervention assessment will be recorded at the initial SLR angle or, if the range decreases, at the new end of the SLR angle.

    Time frame: Before and immediately after intervention

  6. Tampa Scale of Kinesiophobia (TSK-17)

    The Tampa Scale of Kinesiophobia (TSK-17) questionnaire will be used to assess fear of movement (kinesiophobia) at baseline. This questionnaire is commonly used for patients with chronic low back pain and demonstrates good psychometric properties. The TSK-17 score ranges from 17 to 68, with higher scores indicating worse outcomes (greater fear of movement) and lower scores indicating better outcomes (less fear of movement).

    Time frame: At baseline

  7. Score of perceived harmfulness of the movements

    Participants will complete a questionnaire assessing their perceived harmfulness of the movements presented in the videos, using a numerical scale (0 - Not harmful at all, 100 - Extremely harmful). A total of seven movements, corresponding to the AKE, SLR, FTF measurements, passive stretching, and three active stretching exercises, will be presented in the videos. The total score and individual scores for each movement will be analyzed.

    Time frame: At baseline

  8. Skin conductance

    Skin conductance will be measured using a NeuLog device, placed on the fingers of the participant's dominant hand. Fear-related sweat production increases skin conductance and can thus objectively indicate the participant's emotional state. The average amplitude of the Skin Conductance Response will be recorded during both the pre-intervention evaluation and the intervention, measured in µS.

    Time frame: During pre-intervention evaluation and during intervention.

  9. Perceived change in flexibility.

    The participant's declaration of the perceived change in flexibility immediately after the intervention on the movements assessed (AKE, SLR, FTF) will be recorded. The following question will be asked: 'Do you feel a gain in flexibility?' The participant will choose from the following responses: 'No, I feel less flexible,' 'No, I feel no difference,' 'Yes, I feel a little more flexible,' or 'Yes, I feel much more flexible'.

    Time frame: Immediately after the intervention

07

Study locations

2 of 2 sites recruiting
  • Clermont Ferrand Univbersity HOspital, Louise Michel site
    Cébazat, France 63118, France
    Recruiting
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, 63000, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The anonymised individual participant data (IPD) will be sheared on demande.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: The IPD will be shared on demand, starting from the publication of the primary study results, for up to 10 years after study completion.

Access criteria: The anonymized IPD will be sent on demand to qualified researchers or institutions.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Apr 2028, 31 months after the start.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 31 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2025
First posted
Mar 21, 2025
StartActual
Sep 30, 2025
Primary completionEst.
Apr 2028
CompletionEst.
Apr 2028
Last update
Nov 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06888895
Responsible party
Sponsor
First posted
Mar 21, 2025
Start date
Sep 30, 2025
Primary completion
Apr 2028 (estimated)
Completion
Apr 2028 (estimated)
Last update
Nov 25, 2025

Study contacts

Lise Laclautre
Contact
promo_interne_drci@chu-clermontferrand.fr
334-73-754-963
Lech DOBIJA
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion